Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

WuXi AppTec Selected by IQVIA Stem Cell Center to Serve as GMP Manufacturer of Advanced Therapies

Saturday, November 18, 2017

WuXi AppTec WuXi a leading global pharmaceutical biotechnology and medical device openaccess capability and technology platform company announced that its Advanced Therapy Unit based in Philadelphia has been selected as a manufacturing partner for advanced therapies through the California Institute ..

Innovus Pharmaceuticals Strengthens Its Intellectual Property Portfolio with New Patent for Its Sensum+® Product in Mexico

Friday, November 17, 2017

Innovus Pharmaceuticals Inc an emerging overthecounter OTC consumer goods and specialty pharmaceutical company engaged in the commercialization licensing and development of safe and effective nonprescription medicine and consumer care products to improve mens and womens health and vitality and respi..

Nephron Pharmaceuticals Corp. Continues Efforts to Solve Drug Shortage Crisis by Increasing Production and Expanding Capacity

Friday, November 17, 2017

The Nephron sterile compounding division has added 27 new products and installed automated equipment this year to address persistent drug shortages in the United States The damage left by Hurricane Maria to pharmaceutical plants in Puerto Rico amplified the problem for US hospitals In an effort to h..

Arvinas Expands Strategic License Agreement with Genentech

Thursday, November 16, 2017

Arvinas LLC a private biotechnology company creating a new class of drugs based on protein degradation today announced it has expanded its ongoing license agreement with Genentech a member of the Roche Group for the development of new therapeutics using Arvinas39 novel PROTAC technology The multiyea..

Ascentage Pharma Announces U.S. FDA Acceptance of IND Application for Clinical Study of Novel IAP Inhibitor APG-1387

Thursday, November 16, 2017

Ascentage Pharma a global clinicalstage biopharmaceutical company dedicated to developing apoptosistargeted therapies today announced that the US Food and Drug Administration FDA has accepted the Investigational New Drug IND application for APG1387 a novel small molecule IAP inhibitor for the treatm..

Bristol-Myers Squibb and Syngene International Expand Ongoing Research Collaboration

Wednesday, November 15, 2017

Syngene International Indias largest contract research organization today announced that it has expanded its ongoing collaboration with BristolMyers Squibb The next phase of the partnership will see the addition of a new facility to support future BristolMyers Squibb research and development operati..

Purdue Pharma L.P. Announces Strategic Investment in Oncology R&D

Wednesday, November 15, 2017

Purdue Pharma LP today announced completion of significant oncology related investments as part of its ongoing efforts to diversify its scientific research into areas of high unmet medical need Through these investments executed over a multiyear period and capped recently in 2017 Purdue is establish..

Zymeworks Announces License Agreement with Johnson & Johnson Innovation

Tuesday, November 14, 2017

Zymeworks Inc a clinicalstage biopharmaceutical company dedicated to the discovery development and commercialization of nextgeneration multifunctional biotherapeutics today announced it has executed a licensing agreement with Janssen Biotech Inc Janssen one of the Janssen Pharmaceutical Companies of..

Avista Pharma Solutions Doubles API Manufacturing Capacity at Colorado Facility

Tuesday, November 14, 2017

Avista Pharma Solutions Inc has completed facility upgrades that effectively double the companys API manufacturing capacity at its Longmont Colorado site During this expansion the sites three existing GMP drug substance manufacturing suites were upgraded and a fourth GMP suite was added The facility..

GBT acquires Laboratorio DOSA

Monday, November 13, 2017

GBTGrupo Biotoscana a leading biopharmaceutical company in Latin America today announced the acquisition of Laboratorio DOSA a specialty pharmaceutical manufacturer based in Argentina The transaction continues to advance GBT39s strategic agenda and expands GBT39s scope into the promising area of sev..